Similar articles for PMID: 27138271

Year	Number of Results
1999	1
2000	1
2002	1
2004	3
2005	2
2006	2
2007	2
2008	3
2010	1
2011	7
2012	3
2014	7
2015	11
2016	23
2017	15
2018	7
2019	11
2020	10
2021	6
2022	1
2024	0

1

[Resection for advanced pancreatic cancer following multimodal therapy].

Kleeff J, Stöß C, Yip V, Knoefel WT. Kleeff J, et al. Chirurg. 2016 May;87(5):406-12. doi: 10.1007/s00104-016-0184-3. Chirurg. 2016. PMID: 27138271 German.

2

Contemporary strategies to improve the outcome in locally advanced pancreatic cancer.

Schneider R, Späth C, Nitsche U, Erkan M, Kleeff J. Schneider R, et al. Minerva Chir. 2017 Oct;72(5):424-431. doi: 10.23736/S0026-4733.17.07410-7. Epub 2017 May 30. Minerva Chir. 2017. PMID: 28565894 Review.

3

Role of surgery in pancreatic cancer.

Buanes TA. Buanes TA. World J Gastroenterol. 2017 Jun 7;23(21):3765-3770. doi: 10.3748/wjg.v23.i21.3765. World J Gastroenterol. 2017. PMID: 28638216 Free PMC article.

4

Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.

Kwon D, McFarland K, Velanovich V, Martin RC 2nd. Kwon D, et al. Surgery. 2014 Oct;156(4):910-20. doi: 10.1016/j.surg.2014.06.058. Surgery. 2014. PMID: 25239345 Clinical Trial.

5

[Treatment of carcinoma of the pancreatic head].

Hopt UT. Hopt UT. Zentralbl Chir. 2006 Apr;131(2):115-20. doi: 10.1055/s-2006-921535. Zentralbl Chir. 2006. PMID: 16612777 German.

6

Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.

Rose JB, Rocha FG, Alseidi A, Biehl T, Moonka R, Ryan JA, Lin B, Picozzi V, Helton S. Rose JB, et al. Ann Surg Oncol. 2014 May;21(5):1530-7. doi: 10.1245/s10434-014-3486-z. Epub 2014 Jan 29. Ann Surg Oncol. 2014. PMID: 24473642

7

Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.

Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S. Christians KK, et al. Surgery. 2016 Mar;159(3):893-900. doi: 10.1016/j.surg.2015.09.018. Surgery. 2016. PMID: 26602840

8

Localized Pancreatic Cancer: Multidisciplinary Management.

Coveler AL, Herman JM, Simeone DM, Chiorean EG. Coveler AL, et al. Am Soc Clin Oncol Educ Book. 2016;35:e217-26. doi: 10.1200/EDBK_160827. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249726 Free article. Review.

9

Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.

Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG, van Eijck CHJ, Groot Koerkamp B, Rasch CRN, van Tienhoven G; Dutch Pancreatic Cancer Group. Versteijne E, et al. Br J Surg. 2018 Jul;105(8):946-958. doi: 10.1002/bjs.10870. Epub 2018 Apr 30. Br J Surg. 2018. PMID: 29708592 Free PMC article. Review.

10

Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.

Mellon EA, Jin WH, Frakes JM, Centeno BA, Strom TJ, Springett GM, Malafa MP, Shridhar R, Hodul PJ, Hoffe SE. Mellon EA, et al. Acta Oncol. 2017 Mar;56(3):391-397. doi: 10.1080/0284186X.2016.1256497. Epub 2016 Nov 25. Acta Oncol. 2017. PMID: 27885876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year